CARD9 and candidiasis: Our understanding of immunity to Candida infections is largely based on studies of the most common species, C. albicans. Antifungal immunity to C. albicans has been the subject of numerous studies, and a detailed picture of the essential components has emerged, involving a Dectin/CARD9/IL-17 pathway (4).